• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.错配修复基因常见变异与乳腺癌易感性的关联:一项多基因研究。
BMC Cancer. 2009 Sep 25;9:344. doi: 10.1186/1471-2407-9-344.
2
Common variants in mismatch repair genes and risk of invasive ovarian cancer.错配修复基因中的常见变异与侵袭性卵巢癌风险
Carcinogenesis. 2006 Nov;27(11):2235-42. doi: 10.1093/carcin/bgl089. Epub 2006 Jun 13.
3
Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.错配修复单核苷酸多态性与甲状腺癌易感性
Oncol Lett. 2018 May;15(5):6715-6726. doi: 10.3892/ol.2018.8103. Epub 2018 Feb 21.
4
Common variants in mismatch repair genes and risk of colorectal cancer.错配修复基因中的常见变异与结直肠癌风险
Gut. 2008 Aug;57(8):1097-101. doi: 10.1136/gut.2007.137265. Epub 2008 Mar 25.
5
The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk.DNA 错配修复基因多态性与吸烟在食管癌发病风险中的累积效应。
PLoS One. 2012;7(5):e36962. doi: 10.1371/journal.pone.0036962. Epub 2012 May 18.
6
Variations in mismatch repair genes and colorectal cancer risk and clinical outcome.错配修复基因的变异与结直肠癌风险和临床结局。
Mutagenesis. 2014 Jul;29(4):259-65. doi: 10.1093/mutage/geu014. Epub 2014 Apr 22.
7
Correlation between polymorphisms in DNA mismatch repair genes and the risk of primary hepatocellular carcinoma for the Han population in northern China.中国北方汉族人群DNA错配修复基因多态性与原发性肝细胞癌风险的相关性
Scand J Gastroenterol. 2015;50(11):1404-10. doi: 10.3109/00365521.2015.1045429. Epub 2015 May 30.
8
Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer.错配修复基因MSH3多态性与散发性前列腺癌风险相关。
J Urol. 2008 May;179(5):2020-4. doi: 10.1016/j.juro.2008.01.009. Epub 2008 Mar 20.
9
DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.乳腺癌中 DNA 错配修复缺陷:三阴性和非三阴性肿瘤的初步研究。
Am J Surg Pathol. 2012 Nov;36(11):1700-8. doi: 10.1097/PAS.0b013e3182627787.
10
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.采用 PROMISE 分类和额外的 MMR-D 基因分析对 108 例子宫内膜癌患者进行分析。
Gynecol Oncol. 2020 Apr;157(1):245-251. doi: 10.1016/j.ygyno.2020.01.019. Epub 2020 Jan 21.

引用本文的文献

1
DNA damage response in breast cancer and its significant role in guiding novel precise therapies.乳腺癌中的DNA损伤反应及其在指导新型精准治疗中的重要作用。
Biomark Res. 2024 Sep 27;12(1):111. doi: 10.1186/s40364-024-00653-2.
2
Rare Germline Variants in DNA Repair Genes Detected in -Negative Finnish Patients with Early-Onset Breast Cancer.在芬兰早发性乳腺癌阴性患者中检测到的DNA修复基因中的罕见种系变异
Cancers (Basel). 2024 Aug 24;16(17):2955. doi: 10.3390/cancers16172955.
3
Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy through molecular dynamics simulation.通过分子动力学模拟评估 MSH3 和 MSH6 多态性对印度北部接受铂类化疗的肺癌患者风险的影响。
Sci Rep. 2024 Jul 13;14(1):16164. doi: 10.1038/s41598-024-67090-x.
4
DNA repair pathways in breast cancer: from mechanisms to clinical applications.乳腺癌中的 DNA 修复途径:从机制到临床应用。
Breast Cancer Res Treat. 2023 Aug;200(3):305-321. doi: 10.1007/s10549-023-06995-z. Epub 2023 Jun 8.
5
VUS: A functional analysis to differentiate pathogenic from benign variants identified in clinical diagnostic panels for breast cancer.VUS:一种功能分析,用于区分乳腺癌临床诊断面板中发现的致病性和良性变体。
Mol Med Rep. 2023 Jul;28(1). doi: 10.3892/mmr.2023.13023. Epub 2023 May 26.
6
Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients.DNA 修复基因的表观遗传失活可作为膀胱癌患者有前途的预后和预测生物标志物。
Mol Genet Genomics. 2022 Nov;297(6):1671-1687. doi: 10.1007/s00438-022-01950-x. Epub 2022 Sep 8.
7
Male and female breast cancer: the two faces of the same genetic susceptibility coin.男性乳腺癌和女性乳腺癌:同一遗传易感性硬币的两面。
Breast Cancer Res Treat. 2021 Jul;188(1):295-305. doi: 10.1007/s10549-021-06159-x. Epub 2021 May 3.
8
Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.放射性碘治疗分化型甲状腺癌后微核的形成:DNA 修复基因变异的影响。
Genes (Basel). 2020 Sep 17;11(9):1083. doi: 10.3390/genes11091083.
9
DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.散发性实体瘤中的 DNA 错配修复基因变异。
Int J Mol Sci. 2020 Aug 3;21(15):5561. doi: 10.3390/ijms21155561.
10
Identification of High-Order Single-Nucleotide Polymorphism Barcodes in Breast Cancer Using a Hybrid Taguchi-Genetic Algorithm: Case-Control Study.使用混合田口-遗传算法鉴定乳腺癌中的高阶单核苷酸多态性条形码:病例对照研究
JMIR Med Inform. 2020 Jun 17;8(6):e16886. doi: 10.2196/16886.

本文引用的文献

1
Assessment of functional effects of unclassified genetic variants.未分类基因变异的功能效应评估。
Hum Mutat. 2008 Nov;29(11):1314-26. doi: 10.1002/humu.20899.
2
Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk.人类乳腺癌风险中DNA修复基因多态性的多基因模型。
Carcinogenesis. 2008 Nov;29(11):2132-8. doi: 10.1093/carcin/bgn193. Epub 2008 Aug 13.
3
DNA mismatch repair: molecular mechanism, cancer, and ageing.DNA错配修复:分子机制、癌症与衰老
Mech Ageing Dev. 2008 Jul-Aug;129(7-8):391-407. doi: 10.1016/j.mad.2008.02.012. Epub 2008 Mar 4.
4
Macro-environment of breast carcinoma: frequent genetic alterations in the normal appearing skins of patients with breast cancer.乳腺癌的宏观环境:乳腺癌患者外观正常皮肤中的频繁基因改变。
Mod Pathol. 2008 May;21(5):639-46. doi: 10.1038/modpathol.2008.28. Epub 2008 Feb 8.
5
Mechanisms and functions of DNA mismatch repair.DNA错配修复的机制与功能
Cell Res. 2008 Jan;18(1):85-98. doi: 10.1038/cr.2007.115.
6
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.不同人群中与BRCA1和BRCA2相关的乳腺癌风险。
Nat Rev Cancer. 2007 Dec;7(12):937-48. doi: 10.1038/nrc2054.
7
Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk.绝经年龄与XRCC1基因多态性:在乳腺癌风险中的作用
Cancer Detect Prev. 2007;31(4):303-9. doi: 10.1016/j.cdp.2007.07.001.
8
Is MSH2 a breast cancer susceptibility gene?
Fam Cancer. 2008;7(2):151-5. doi: 10.1007/s10689-007-9162-8. Epub 2007 Oct 6.
9
Modelling breast cancer: one size does not fit all.乳腺癌建模:一刀切并不适用。
Nat Rev Cancer. 2007 Sep;7(9):659-72. doi: 10.1038/nrc2193.
10
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.62个DNA修复基因中的多态性发现以及与肺癌、头颈癌风险的单倍型关联。
Carcinogenesis. 2007 Aug;28(8):1731-9. doi: 10.1093/carcin/bgm111. Epub 2007 May 10.

错配修复基因常见变异与乳腺癌易感性的关联:一项多基因研究。

Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.

机构信息

Department of Genetics, Faculty of Medical Sciences, New University of Lisbon, Rua da Junqueira 96, P-1349-008 Lisboa, Portugal.

出版信息

BMC Cancer. 2009 Sep 25;9:344. doi: 10.1186/1471-2407-9-344.

DOI:10.1186/1471-2407-9-344
PMID:19781088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2761943/
Abstract

BACKGROUND

MMR is responsible for the repair of base-base mismatches and insertion/deletion loops. Besides this, MMR is also associated with an anti-recombination function, suppressing homologous recombination. Losses of heterozygosity and/or microsatellite instability have been detected in a large number of skin samples from breast cancer patients, suggesting a potential role of MMR in breast cancer susceptibility.

METHODS

We carried out a hospital-based case-control study in a Caucasian Portuguese population (287 cases and 547 controls) to estimate the susceptibility to non-familial breast cancer associated with some polymorphisms in mismatch repair genes (MSH3, MSH4, MSH6, MLH1, MLH3, PMS1 and MUTYH).

RESULTS

Using unconditional logistic regression we found that MLH3 (L844P, G>A) polymorphism GA (Leu/Pro) and AA (Pro/Pro) genotypes were associated with a decreased risk: OR = 0.65 (0.45-0.95) (p = 0.03) and OR = 0.62 (0.41-0.94) (p = 0.03), respectively.Analysis of two-way SNP interaction effects on breast cancer revealed two potential associations to breast cancer susceptibility: MSH3 Ala1045Thr/MSH6 Gly39Glu - AA/TC [OR = 0.43 (0.21-0.83), p = 0.01] associated with a decreased risk; and MSH4 Ala97Thr/MLH3 Leu844Pro - AG/AA [OR = 2.35 (1.23-4.49), p = 0.01], GG/AA [OR = 2.11 (1.12-3,98), p = 0.02], and GG/AG [adjusted OR = 1.88 (1.12-3.15), p = 0.02] all associated with an increased risk for breast cancer.

CONCLUSION

It is possible that some of these common variants in MMR genes contribute significantly to breast cancer susceptibility. However, further studies with a large sample size will be needed to support our results.

摘要

背景

MMR 负责修复碱基对错配和插入/缺失环。除此之外,MMR 还与抗重组功能有关,抑制同源重组。在大量乳腺癌患者的皮肤样本中已经检测到杂合性丢失和/或微卫星不稳定性,这表明 MMR 在乳腺癌易感性中可能起作用。

方法

我们在一个葡萄牙白种人人群中进行了一项基于医院的病例对照研究(287 例病例和 547 例对照),以估计非家族性乳腺癌与错配修复基因(MSH3、MSH4、MSH6、MLH1、MLH3、PMS1 和 MUTYH)中一些多态性相关的易感性。

结果

使用无条件逻辑回归,我们发现 MLH3(L844P、G>A)多态性 GA(亮氨酸/脯氨酸)和 AA(脯氨酸/脯氨酸)基因型与降低的风险相关:OR = 0.65(0.45-0.95)(p = 0.03)和 OR = 0.62(0.41-0.94)(p = 0.03)。对乳腺癌的双向 SNP 相互作用效应分析显示,有两个潜在的关联与乳腺癌易感性有关:MSH3 Ala1045Thr/MSH6 Gly39Glu-AA/TC [OR = 0.43(0.21-0.83),p = 0.01] 与降低的风险相关;以及 MSH4 Ala97Thr/MLH3 Leu844Pro-AG/AA [OR = 2.35(1.23-4.49),p = 0.01]、GG/AA [OR = 2.11(1.12-3.98),p = 0.02]和 GG/AG [调整后的 OR = 1.88(1.12-3.15),p = 0.02] 均与乳腺癌风险增加相关。

结论

这些 MMR 基因中的一些常见变体可能对乳腺癌易感性有重要贡献。然而,需要更大样本量的进一步研究来支持我们的结果。